Entyvio

Product NDC
64764-300
11-digit product format
647640300
Labeler code
64764
Product ID
64764-300_266293d6-dd28-4e38-81c2-4f518d95ef5d
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
vedolizumab
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Labeler
Takeda Pharmaceuticals America, Inc.
Application
BLA125476
Marketing category
BLA
Marketing start
2014-05-20
Substance
VEDOLIZUMAB
Active strength
300 mg/5mL
Pharmacologic classes
Integrin Receptor Antagonist [EPC], Integrin Receptor Antagonists [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Entyvio
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
VEDOLIZUMAB300 mg/5mL

Harmonized Identifiers#

Field, Values table
FieldValues
Unii9RV78Q2002
Rxcui1538137, 1538142, 2667332, 2667336, 2667339, 2667342

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
1736508a-7179-4f90-8972-12f94dcb872fProduct name220250624
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324
1681bc73-b05f-12c3-1075-382ae39f449cProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
64764-300-20Entyvio1 in 1 CARTONINJECTION, POWDER, LYOPHILIZED,126
64764-300-20Entyvio5 mL in 1 VIAL, SINGLE-DOSEINJECTION, POWDER, LYOPHILIZED,526

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
64764-300ENTYVIO (VEDOLIZUMAB) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION ENTYVIO PEN (VEDOLIZUMAB) INJECTION, SOLUTION ENTYVIO (VEDOLIZUMAB) INJECTION, SOLUTION [TAKEDA PHARMACEUTICALS AMERICA, INC.]20Current NDC, Legacy NDC, 2 package rows20240612_6e94621c-1a95-4af9-98d1-52b9e6f1949c.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
2667336ENTYVIO 108 MG in 0.68 ML Prefilled SyringePSN6e94621c-1a95-4af9-98d1-52b9e6f1949c26
1538142Entyvio 300 MG InjectionPSN6e94621c-1a95-4af9-98d1-52b9e6f1949c26
2667342ENTYVIO PEN 108 MG in 0.68 ML Auto-InjectorPSN6e94621c-1a95-4af9-98d1-52b9e6f1949c26
2667339vedolizumab 108 MG in 0.68 ML Auto-InjectorPSN6e94621c-1a95-4af9-98d1-52b9e6f1949c26
2667332vedolizumab 108 MG in 0.68 ML Prefilled SyringePSN6e94621c-1a95-4af9-98d1-52b9e6f1949c26
1538137vedolizumab 300 MG InjectionPSN6e94621c-1a95-4af9-98d1-52b9e6f1949c26
26673420.68 ML vedolizumab 159 MG/ML Auto-Injector [Entyvio]SBD6e94621c-1a95-4af9-98d1-52b9e6f1949c26
26673360.68 ML vedolizumab 159 MG/ML Prefilled Syringe [Entyvio]SBD6e94621c-1a95-4af9-98d1-52b9e6f1949c26
1538142vedolizumab 300 MG Injection [Entyvio]SBD6e94621c-1a95-4af9-98d1-52b9e6f1949c26
26673390.68 ML vedolizumab 159 MG/ML Auto-InjectorSCD6e94621c-1a95-4af9-98d1-52b9e6f1949c26
26673320.68 ML vedolizumab 159 MG/ML Prefilled SyringeSCD6e94621c-1a95-4af9-98d1-52b9e6f1949c26
1538137vedolizumab 300 MG InjectionSCD6e94621c-1a95-4af9-98d1-52b9e6f1949c26
26673420.68 ML Entyvio 159 MG/ML Auto-InjectorSY6e94621c-1a95-4af9-98d1-52b9e6f1949c26
26673360.68 ML Entyvio 159 MG/ML Prefilled SyringeSY6e94621c-1a95-4af9-98d1-52b9e6f1949c26
2667342Entyvio 108 MG per 0.68 ML Auto-InjectorSY6e94621c-1a95-4af9-98d1-52b9e6f1949c26
2667336Entyvio 108 MG per 0.68 ML Prefilled SyringeSY6e94621c-1a95-4af9-98d1-52b9e6f1949c26
1538142Entyvio 300 MG InjectionSY6e94621c-1a95-4af9-98d1-52b9e6f1949c26
2667339vedolizumab 108 MG per 0.68 ML Auto-InjectorSY6e94621c-1a95-4af9-98d1-52b9e6f1949c26
2667332vedolizumab 108 MG per 0.68 ML Prefilled SyringeSY6e94621c-1a95-4af9-98d1-52b9e6f1949c26

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
64764-300-20647640300201 VIAL, SINGLE-DOSE in 1 CARTON (64764-300-20) / 5 mL in 1 VIAL, SINGLE-DOSE2014-05-200000-00-00NoNoCurrent